Short Interest in Morningstar US Industrials (NASDAQ:MIST) Drops By 6.1%

Morningstar US Industrials (NASDAQ:MIST) was the target of a large drop in short interest during the month of October. As of October 31st, there was short interest totalling 342,000 shares, a drop of 6.1% from the October 15th total of 364,300 shares. Based on an average daily volume of 74,700 shares, the days-to-cover ratio is currently 4.6 days.

Institutional Investors Weigh In On Morningstar US Industrials

A number of hedge funds and other institutional investors have recently made changes to their positions in MIST. BNP Paribas Arbitrage SA acquired a new stake in shares of Morningstar US Industrials in the first quarter valued at approximately $25,000. BNP Paribas Arbitrage SNC raised its position in shares of Morningstar US Industrials by 402.6% in the second quarter. BNP Paribas Arbitrage SNC now owns 10,810 shares of the company’s stock valued at $31,000 after buying an additional 8,659 shares in the last quarter. Virtu Financial LLC acquired a new position in shares of Morningstar US Industrials in the 2nd quarter valued at approximately $33,000. Beta Wealth Group Inc. acquired a new position in shares of Morningstar US Industrials in the 2nd quarter valued at approximately $40,000. Finally, Delphia USA Inc. acquired a new position in shares of Morningstar US Industrials in the 4th quarter valued at approximately $50,000. 61.32% of the stock is currently owned by institutional investors and hedge funds.

Morningstar US Industrials Stock Performance

NASDAQ:MIST opened at $2.20 on Friday. The stock has a market cap of $73.66 million, a P/E ratio of -1.59 and a beta of 1.82. The stock has a 50 day simple moving average of $2.82 and a 200 day simple moving average of $3.21. The company has a current ratio of 10.45, a quick ratio of 13.89 and a debt-to-equity ratio of 1.72. Morningstar US Industrials has a 1-year low of $2.15 and a 1-year high of $5.20.

Morningstar US Industrials (NASDAQ:MIST) last released its quarterly earnings results on Monday, November 13th. The company reported ($0.35) earnings per share for the quarter, beating analysts’ consensus estimates of ($0.38) by $0.03. Research analysts anticipate that Morningstar US Industrials will post -1.46 earnings per share for the current year.

Wall Street Analysts Forecast Growth

Separately, HC Wainwright reissued a “buy” rating and set a $25.00 price target on shares of Morningstar US Industrials in a report on Monday, August 14th.

Morningstar US Industrials Company Profile

Milestone Pharmaceuticals, Inc engages in the development and commercialization of cardiovascular medicines. Its lead product candidate etripamil, is a novel, potent and short-acting calcium channel blocker that is designed as a rapid-onset nasal spray to be self-administered by patients. It develops etripamil to treat paroxysmal supraventricular tachycardia, atrial fibrillation, rapid ventricular rate, and other cardiovascular indications.